| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 70.509 | 71.143 | 77.803 | 82.017 | 103.952 | 89.416 | 215.545 | 191.293 | 175.229 | 204.162 |
| Total Income - EUR | 75.655 | 75.957 | 82.528 | 83.069 | 132.350 | 118.450 | 251.842 | 216.916 | 196.614 | 229.404 |
| Total Expenses - EUR | 31.261 | 33.987 | 44.397 | 35.423 | 66.283 | 112.014 | 140.270 | 124.624 | 136.602 | 142.092 |
| Gross Profit/Loss - EUR | 44.394 | 41.970 | 38.131 | 47.646 | 66.067 | 6.436 | 111.572 | 92.293 | 60.012 | 87.312 |
| Net Profit/Loss - EUR | 37.143 | 41.258 | 37.353 | 46.828 | 65.074 | 5.887 | 109.620 | 90.580 | 58.729 | 81.309 |
| Employees | 3 | 3 | 3 | 2 | 4 | 4 | 5 | 0 | 4 | 4 |
Check the financial reports for the company - Neurolife Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 119.657 | 109.953 | 128.521 | 120.230 | 326.087 | 625.590 | 618.504 | 585.320 | 551.502 | 515.957 |
| Current Assets | 24.544 | 4.284 | 9.950 | 60.357 | 332.568 | 136.525 | 90.061 | 32.676 | 33.963 | 14.469 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 46 | 0 | 0 | 0 | 12 |
| Receivables | 5.043 | 3.955 | 3.652 | 4.670 | 271.503 | 127.703 | 54.508 | 9.959 | 16.017 | 8.888 |
| Cash | 19.501 | 328 | 6.298 | 55.687 | 61.065 | 8.776 | 35.552 | 22.717 | 17.946 | 5.569 |
| Shareholders Funds | 125.890 | 88.073 | 123.936 | 168.489 | 230.300 | 226.380 | 325.107 | 90.628 | 149.082 | 81.357 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.734 | 26.163 | 13.693 | 12.098 | 28.819 | 161.289 | 54.709 | 219.443 | 150.774 | 184.320 |
| Income in Advance | 10.577 | 5.663 | 842 | 0 | 399.536 | 374.446 | 328.748 | 307.925 | 285.608 | 264.748 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurolife Srl